Peptides are having a moment.

Depending on who you follow online, they can help you build muscle, lose fat, recover faster, sleep better, improve your libido, heal injuries and look younger.

I may have to be the bearer of bad news.

The word peptide doesn’t mean natural. It doesn’t mean safe. It describes a molecule made from a relatively short chain of amino acids.

That’s chemistry, not a Good Housekeeping seal.

And peptides can be remarkably powerful.

Semaglutide (aka Ozempic) is a peptide-based medication.

I’ve written favorably about GLP-1 drugs because we have substantial clinical data telling us what they do, who benefits, what the risks are and how they should be monitored.

That’s what makes the current peptide conversation so strange.

In some corners of the internet, semaglutide gets dismissed as a scary “drug,” while another peptide ordered online gets presented as the more natural alternative.

They’re both pharmacology.

The difference is what we know about them.

A 2026 review of peptides promoted for recovery and performance found that about two-thirds of the published research was still in animals.

Human studies were few and generally weak.

The authors concluded that the claimed benefits remain unsubstantiated by current human trials.

That’s a pretty big gap between Instagram and science.

There’s also a more basic problem: what exactly is in the vial?

With products coming from unregulated or gray-market sources, purity, potency and sterility aren’t assumptions I’m willing to make.

“Research use only” doesn’t become reassuring because the guy recommending it has eight percent body fat and a discount code.

That’s not gatekeeping a miracle. It’s stewardship.

Even the regulatory picture is confusing.

The FDA has recently reconsidered how some peptides should be regulated, and there is a legitimate debate about whether our drug-development and approval processes have become too slow, expensive and cumbersome.

I’m open to that argument.

But changing a regulatory designation isn’t the same thing as producing new evidence.

Patient-safety organizations recently made exactly that point after the status of several peptides changed without new clinical data demonstrating their safety or effectiveness.

Making it easier to study and responsibly use promising compounds is one conversation.

Allowing a gray market to outrun science is another.

And to those who say, “We’ve been eating peptides for millennia,” that’s true.

But the gray-market peptides we’re talking about aren’t the peptides in your dinner.

They’re synthesized in a lab and administered for a pharmacologic effect.

Calling them “natural” doesn’t tell us whether they’re safe, effective, pure or sterile.

I’m not anti-peptide. Quite the opposite.

The next important drug in men’s health may very well be a peptide.

These molecules can be pharmacologically powerful, and that’s precisely why I take them seriously.

If something is powerful enough to change your metabolism, increase muscle, alter inflammation or affect sexual function, it’s powerful enough for me to want to know what else it does.

So if the next peptide turns out to be extraordinary, I’ll happily change my mind when the evidence gets there.

Until then, I’ll take clinical trials, reliable manufacturing and boring pharmacology over the spray-tanned guy in a muscle shirt repping a mail-order peptide shop.

He may eventually be right.

I’d just prefer something better than his abs as the supporting data.